Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Spinal Cord Injury |
Borcek, Alp Ozgun
(Department of Neurosurgery, Gazi University Faculty of Medicine)
Civi, Soner (Department of Neurosurgery, Medicana Private Hospital) Ocal, Ozgur (Department of Neurosurgery, Gazi University Faculty of Medicine) Gulbahar, Ozlem (Department of Biochemistry, Gazi University Faculty of Medicine) |
1 | Bracken MB : Methylprednisolone and acute spinal cord injury : an update of the randomized evidence. Spine (Phila Pa 1976) 26 (24 Suppl) : S47-S54, 2001 DOI |
2 | Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A : Tumor necrosis factor alpha blockers and malignancy in children : forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 62 : 2517-2524, 2010 DOI |
3 | Kurt G, Cemil B, Borcek AO, Borcek P, Akyurek N, Sepici A, et al. : Infliximab administration reduces neuronal apoptosis on the optic pathways in a rabbit hydrocephalus model : a preliminary report. Br J Neurosurg 24 : 275-279, 2010 |
4 | Wang CX, Nuttin B, Heremans H, Dom R, Gybels J : Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol 69 : 151-156, 1996 DOI |
5 | Reinisch W, Sandborn WJ, Hommes DW, D'Haens G, Hanauer S, Schreiber S, et al. : Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis : results of a randomised controlled trial. Gut 60 : 780-787, 2011 DOI |
6 | Beattie MS, Hermann GE, Rogers RC, Bresnahan JC : Cell death in models of spinal cord injury. Prog Brain Res 137 : 37-47, 2002 DOI |
7 | Balentine JD : Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest 39 : 236-253, 1978 |
8 | Balentine JD : Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest 39 : 254-266, 1978 |
9 | Bayrakli F, Balaban H, Ozum U, Duger C, Topaktas S, Kars HZ : Etanercept treatment enhances clinical and neuroelectrophysiological recovery in partial spinal cord injury. Eur Spine J 21 : 2588-2593, 2012 DOI |
10 | Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, et al. : Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16 : 851-863, 1999 DOI |
11 | Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, et al. : Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251 : 45-52, 1984 DOI |
12 | Blight AR : Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 9 Suppl 1 : S83-S91, 1992 |
13 | Bracken MB : Methylprednisolone in the management of acute spinal cord injuries. Med J Aust 153 : 368, 1990 |
14 | Bracken MB : Steroids for acute spinal cord injury. Cochrane Database Syst Rev 1 : CD001046, 2012 |
15 | Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. : A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322 : 1405-1411, 1990 DOI |
16 | Bracken MB, Shepard MJ, Hellenbrand KG, Collins WF, Leo LS, Freeman DF, et al. : Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 63 : 704-713, 1985 DOI |
17 | Burmester GR, Mease P, Dijkmans BA, Gordon K, Lovell D, Panaccione R, et al. : Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis 68 : 1863-1869, 2009 DOI |
18 | Burness CB, Keating GM : Adalimumab : a review of its use in the treatment of patients with ulcerative colitis. BioDrugs 27 : 247-262, 2013 DOI |
19 | Caminero A, Comabella M, Montalban X : Tumor necrosis factor alpha (TNF-), anti-TNF- and demyelination revisited : an ongoing story. J Neuroimmunol 234 : 1-6, 2011 DOI |
20 | Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L : Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151 : 77-88, 1998 DOI |
21 | Catala A : Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/ or pathological conditions. Chem Phys Lipids 157 : 1-11, 2009 DOI |
22 | Ducker TB, Kindt GW, Kempf LG : Pathological findings in acute experimental spinal cord trauma. J Neurosurg 35 : 700-708, 1971 DOI |
23 | Emmez H, Borcek AO, Kaymaz M, Kaymaz F, Durdag E, Civi S, et al. : Neuroprotective effects of gabapentin in experimental spinal cord injury. World Neurosurg 73 : 729-734, 2010 DOI |
24 | Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, et al. : The cellular inflammatory response in human spinal cords after injury. Brain 129 (Pt 12) : 3249-3269, 2006 DOI |
25 | Grotto D, Maria LS, Valentini J, Paniz C, Schmitt G, Garcia SC, et al. : Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quim Nova 32 : 169-174, 2009 DOI |
26 | Guadagno J, Xu X, Karajgikar M, Brown A, Cregan SP : Microglia-derived TNF induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma. Cell Death Dis 4 : e538, 2013 DOI |
27 | Guven C, Borcek AO, Cemil B, Kurt G, Yildirim Z, Ucankus NL, et al. : Neuroprotective effects of infliximab in experimental spinal cord ischemic injury. J Clin Neurosci 17 : 1563-1567, 2010 DOI |
28 | Hall ED : Inhibition of lipid peroxidation in CNS trauma. J Neurotrauma 8 Suppl 1 : S31-S40; discussion S41, 1991 |
29 | Hall ED, Braughler JM : Free radicals in CNS injury. Res Publ Assoc Res Nerv Ment Dis 71 : 81-105, 1993 |
30 | Hamada Y, Ikata T, Katoh S, Nakauchi K, Niwa M, Kawai Y, et al. : Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J Neurochem 66 : 1525-1531, 1996 |
31 | Harrington JF, Messier AA, Levine A, Szmydynger-Chodobska J, Chodobski A : Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma 22 : 919-928, 2005 DOI |
32 | Kaymakcalan Z, Sakorafas P, Bose S, Scesney S, Xiong L, Hanzatian DK, et al. : Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 131 : 308-316, 2009 DOI |
33 | Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, et al. : Stimulation of neutrophils by tumor necrosis factor. J Immunol 136 : 4220-4225, 1986 |
34 | Kurt G, Ergun E, Cemil B, Borcek AO, Börcek P, Gulbahar O, et al. : Neuroprotective effects of infliximab in experimental spinal cord injury. Surg Neurol 71 : 332-336; discussion 336, 2009 DOI |
35 | Kwon BK, Okon E, Hillyer J, Mann C, Baptiste D, Weaver LC, et al. : A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma 28 : 1545-1588, 2011 DOI |
36 | Mihara M, Uchiyama M : Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86 : 271-278, 1978 DOI |
37 | Papakostas JC, Matsagas MI, Toumpoulis IK, Malamou-Mitsi VD, Pappa LS, Gkrepi C, et al. : Evolution of spinal cord injury in a porcine model of prolonged aortic occlusion. J Surg Res 133 : 159-166, 2006 DOI |
38 | Sekhon LH, Fehlings MG : Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 26 (24 Suppl): S2-S12, 2001 DOI |
39 | Yu SH, Cho DC, Kim KT, Nam KH, Cho HJ, Sung JK : The neuroprotective effect of treatment of valproic Acid in acute spinal cord injury. J Korean Neurosurg Soc 51 : 191-198, 2012 DOI |
40 | Tang X, Wang Y, Zhou S, Qian T, Gu X : Signaling pathways regulating dose-dependent dual effects of TNF- on primary cultured Schwann cells. Mol Cell Biochem 378 : 237-246, 2013 DOI |